These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
11351 related items for PubMed ID: 15627046
1. [Antipsychotics in bipolar disorders]. Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L. Encephale; 2004; 30(5):417-24. PubMed ID: 15627046 [Abstract] [Full Text] [Related]
3. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N. Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393 [Abstract] [Full Text] [Related]
4. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cipriani A, Reid K, Young AH, Macritchie K, Geddes J. Cochrane Database Syst Rev; 2013 Oct 17; 2013(10):CD003196. PubMed ID: 24132760 [Abstract] [Full Text] [Related]
7. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G, Godart N. Encephale; 2017 Oct 17; 43(5):464-470. PubMed ID: 27871720 [Abstract] [Full Text] [Related]
12. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. J Clin Psychiatry; 2009 Oct 17; 70(10):1424-31. PubMed ID: 19906346 [Abstract] [Full Text] [Related]
13. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. Maher AR, Theodore G. J Manag Care Pharm; 2012 Jun 17; 18(5 Suppl B):S1-20. PubMed ID: 22784311 [Abstract] [Full Text] [Related]
14. Valproate for acute mania. Jochim J, Rifkin-Zybutz RP, Geddes J, Cipriani A. Cochrane Database Syst Rev; 2019 Oct 07; 10(10):CD004052. PubMed ID: 31621892 [Abstract] [Full Text] [Related]
15. McDonagh M, Peterson K, Carson S, Fu R, Thakurta S. ; 2010 07 07. PubMed ID: 21348048 [Abstract] [Full Text] [Related]
16. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I. Encephale; 2005 07 07; 31(2):235-46. PubMed ID: 15959450 [Abstract] [Full Text] [Related]
17. Bipolar depression: the role of atypical antipsychotics. Post RM, Calabrese JR. Expert Rev Neurother; 2004 Nov 07; 4(6 Suppl 2):S27-33. PubMed ID: 16279863 [Abstract] [Full Text] [Related]
18. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J. Eur Neuropsychopharmacol; 2009 Jul 07; 19(7):520-32. PubMed ID: 19411165 [Abstract] [Full Text] [Related]
19. Rational polypharmacy in the bipolar affective disorders. Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M. Epilepsy Res Suppl; 1996 Jul 07; 11():153-80. PubMed ID: 9294735 [Abstract] [Full Text] [Related]
20. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. Miller DS, Yatham LN, Lam RW. J Clin Psychiatry; 2001 Dec 07; 62(12):975-80. PubMed ID: 11780879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]